HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Post-Pandemic Stocks

925.265

-8.623-0.92%

Number of Gainers:2

Number of Losers:15

Number of Flat:- -

PE:- -

High:930.611

Open:930.611

Low:904.457

Close:933.888

Volume:536.53M

Turnover:4.82B

Market Cap:620.70B

Float Cap:517.91B

Loading ...

CanSino Biologics Surges Over 35% as Analysts See Parallels with Moderna's Vaccine Platform

CLSA Says CansinoBio Shares Surge as Moderna's mRNA Cancer Vaccine Succeeds in Late-Stage Trial

Citi Lifts SBP GROUP Price Target to HK$10.8, Citing Strong H1 Beat

Hong Kong Stock Movers | Sihuan Pharma Surges Over 6% on Strong H1 Profit Forecast and Expanding Aesthetic Medicine Business

Historic mRNA Cancer Vaccine Breakthrough Sends Pharmaceutical Stocks Soaring on US, A-share, and HK Markets

Norway's Vistin Pharma Q2 Revenue Falls on Currency Impact

CSPC Pharma (01093) Surges Over 12% After Interim Profit Jumps Nearly 1.4-Fold

CSPC Pharmaceutical Hits 6-Month High on Profit, Dividend Surge

Finland's Nanoform Q2 Ebitda Loss Narrows on Layoffs, Cost Cuts

CSPC Pharmaceutical's Attributable Profit More Than Doubles in H1; Shares Jump 14%

MT Newswires Live

CSPC Pharma FY26 H1 Profit Attributable to Shareholders More than Doubled to RMB 6.09 Billion; Revenue Rises 40.1% to RMB 18.59 Billion

CSPC Pharmaceutical Group H1 Net Income Attributable RMB 6,094.2 Million

THOMSON REUTERS

CSPC Pharmaceutical Group - Interim Dividend of HK18 Cents Per Share for 2026

THOMSON REUTERS

Market Opens Higher Across All Three Major Indices, Led by Precious Metals and Pharmaceuticals

Sinopharm to Sell 51% Stake in Guorui Pharmaceutical for 406 Million Yuan

MT Newswires Live

Hong Kong Stock Market Update: SBP GROUP Jumps Over 6% After Results, H1 Revenue Hits Record 19.44 Billion Yuan, Gaining Endorsements From Top Global Pharmaceutical Firms

Hong Kong Stock Alert: CansinoBio Jumps 15% as mRNA Cancer Vaccine Sector Gets Major Boost

US Treasury Steps In to Calm Markets, Ending Wall Street's Three-Day Slide, While Moderna's Cancer Vaccine Breakthrough Sends Shares Soaring 176%

GENFLEET-B Advances Two First-in-Class Pancreatic Cancer Combination Therapies into Phase II Trials

China's Ascentage Pharma H1 Revenue Rises 29% on Lisaftoclax Ramp-up

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/BK1515/news?page=12"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1515","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1515\",,,,,undefined,":{"symbol":"BK1515","market":"HK","secType":"PLATE","nameCN":"Post-Pandemic Stocks","latestPrice":925.2649,"timestamp":1788163726135,"preClose":933.88794,"halted":0,"volume":536532085,"delay":0,"changeRate":-0.009233,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Closed","change":-8.623047,"latestTime":"08-31 16:00:00","open":930.611,"high":930.611,"low":904.4565,"amount":4819960565.96,"amplitude":0.028006,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1788226200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1788139800000,1788148800000],[1788152400000,1788163200000]],"pbRate":1.403188,"peRate":17.015388,"turnoverRate":0.006128,"increases":2,"decrements":15,"flats":0,"marketCap":620699252288,"floatMarketCap":517907756096},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1515\",,,,,undefined,":{"symbol":"BK1515","high":930.611,"amplitude":0.028006,"preClose":933.88794,"low":904.4565,"pbRate":"1.403188","latestPrice":925.2649,"volume":536532085,"delay":0,"open":930.611,"prevYearClose":1190.107,"prevWeekClose":933.888,"prevMonthClose":925.972,"prevQuarterClose":802.777,"fiveDayClose":929.009,"twentyDayClose":928.063,"sixtyDayClose":909.52,"secType":"PLATE","market":"HK","turnoverRate":0.006128,"peRate":17.015388,"marketCap":620699252288,"floatMarketCap":517907756096,"timestamp":1788163726135,"nameCN":"Post-Pandemic Stocks"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1515\",,,,undefined,":{"bkCode":"BK1515","up":2,"down":15,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1515\",pageSize:20,pageCount:12,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1146689374","title":"CanSino Biologics Surges Over 35% as Analysts See Parallels with Moderna's Vaccine Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=1146689374","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1146689374?lang=en_us&edition=fundamental","pubTime":"2026-08-20 15:58","pubTimestamp":1787212701,"startTime":"0","endTime":"0","summary":"Shares of CanSino Biologics (06185.HK) experienced a dramatic surge during Tuesday's trading session, climbing more than 60% in early deals before paring gains to close the morning up 35.82% at...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","BK1161","06185","BK1574","BK4585","BK4588","KCAI","BK1191","VXUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141282222","title":"CLSA Says CansinoBio Shares Surge as Moderna's mRNA Cancer Vaccine Succeeds in Late-Stage Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=1141282222","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1141282222?lang=en_us&edition=fundamental","pubTime":"2026-08-20 15:42","pubTimestamp":1787211738,"startTime":"0","endTime":"0","summary":"Shares of CansinoBio (06185) jumped more than 50% in half a day of trading, driven by positive results from Moderna's (MRNA.US) Phase 3 clinical trial for its mRNA cancer vaccine, according to a...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","BK1574","159646","06185","BK1161","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1147356338","title":"Citi Lifts SBP GROUP Price Target to HK$10.8, Citing Strong H1 Beat","url":"https://stock-news.laohu8.com/highlight/detail?id=1147356338","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1147356338?lang=en_us&edition=fundamental","pubTime":"2026-08-20 15:30","pubTimestamp":1787211022,"startTime":"0","endTime":"0","summary":"Citi has reiterated its \"Buy\" rating on SBP GROUP (01177), raising the target price from HK$10 to HK$10.8 following the company's better-than-expected first-half results.The pharmaceutical firm...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BSNM7G36.USD","LU2236285917.USD","LU0320765646.SGD","LU0072461881.USD","BK4566","EWH","FTXO","BK1191","LU1244550494.USD","LU0980610538.SGD","IE00BZ08YS42.EUR","LU0162691827.USD","LU0130517989.USD","LU2360032135.SGD","LU0203345920.USD","LU0098860793.USD","LU0130102774.USD","TFNS","LU2417539215.USD","BK4207","LU1244550577.SGD","LU0314106906.USD","BK4585","IE00BZ08YR35.GBP","LU0052756011.USD","LU1668664300.SGD","LU0170899867.USD","BK1515","LU2125154778.USD","LU0477156953.USD","BK4534","LU1144417596.USD","LU0648001328.SGD","LU1366192091.USD","IYF","LU1267930227.SGD","LU2462157665.USD","C","LU1791807156.HKD","BK1589","LU1074936037.SGD","LU0310800965.SGD","BK4588","HK0000165453.HKD","LU0106831901.USD","BK1521","LU0203347892.USD","LU1201861249.SGD","LU2456880835.USD","LU1506573853.SGD","01177","BK4504","BK4559","LU1162221912.USD","LU2125154935.USD","IE00BZ08YT58.USD","LU1244550221.USD","LU0128525689.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1156555320","title":"Hong Kong Stock Movers | Sihuan Pharma Surges Over 6% on Strong H1 Profit Forecast and Expanding Aesthetic Medicine Business","url":"https://stock-news.laohu8.com/highlight/detail?id=1156555320","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1156555320?lang=en_us&edition=fundamental","pubTime":"2026-08-20 14:24","pubTimestamp":1787207055,"startTime":"0","endTime":"0","summary":"SIHUAN PHARM (00460) shares climbed more than 6% in Hong Kong trading on Tuesday, with the stock last up 6.47% at HK$0.905, on turnover of HK$36.93 million.The rally follows the company's positive...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1600","KCAI","00460","BK1593","BK1191","BK1515","BK4585","VXUS","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102476446","title":"Historic mRNA Cancer Vaccine Breakthrough Sends Pharmaceutical Stocks Soaring on US, A-share, and HK Markets","url":"https://stock-news.laohu8.com/highlight/detail?id=1102476446","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1102476446?lang=en_us&edition=fundamental","pubTime":"2026-08-20 14:10","pubTimestamp":1787206241,"startTime":"0","endTime":"0","summary":"A landmark event has shaken the pharmaceutical world. Moderna and Merck announced that their jointly developed personalized mRNA cancer vaccine, Intismeran (V940), successfully met both the...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["520880","BK1161","BK1574","09939","159646","BK1515","01477","BK1191","159938"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660926405","title":"Norway's Vistin Pharma Q2 Revenue Falls on Currency Impact","url":"https://stock-news.laohu8.com/highlight/detail?id=2660926405","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660926405?lang=en_us&edition=fundamental","pubTime":"2026-08-20 13:54","pubTimestamp":1787205278,"startTime":"0","endTime":"0","summary":"Norway's Vistin Pharma Q2 revenue falls on currency impactOverviewNorway pharmaceutical maker's Q2 revenue fell yr/yr due to stronger NOK despite 8% sales volume growthQ2 EBITDA and net profit decline","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nL1N44H068:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2039709279.SGD","LU1008478684.HKD","BK1521","LU0072913022.USD","LU1226288170.HKD","LU1993786604.SGD","LU0501845795.SGD","01093","LU0067412154.USD","LU1152091168.USD","LU1226287792.SGD","LU0326950275.SGD","LU1807302812.USD","LU0315179316.USD","LU0880133367.SGD","LU1813983027.USD","IE00B5MMRT66.SGD","IE0008369823.USD","BK1515","IE0008368742.USD","LU1226287529.USD","LU1951186391.HKD","LU1226288253.USD","LU0314109678.HKD","IE00BZ08YT58.USD","LU0140636845.USD","LU1328277881.USD","IE00B031HY20.USD","LU1226287875.USD","SG9999004220.SGD","IE00B543WZ88.USD","IE00BZ08YS42.EUR","IE00BZ08YR35.GBP","LU1152091754.HKD","LU1960683339.HKD","KURE","HK0000165453.HKD","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1189336205","title":"CSPC Pharma (01093) Surges Over 12% After Interim Profit Jumps Nearly 1.4-Fold","url":"https://stock-news.laohu8.com/highlight/detail?id=1189336205","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1189336205?lang=en_us&edition=fundamental","pubTime":"2026-08-20 13:40","pubTimestamp":1787204412,"startTime":"0","endTime":"0","summary":"Shares of CSPC PHARMA (01093) climbed more than 12% following its interim results announcement, trading up 11.97% at HK$9.725 with turnover reaching HK$3.057 billion as of press time.On August 20 at...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK1521","LU0140636845.USD","LU1008478684.HKD","LU1152091754.HKD","IE00BZ08YS42.EUR","LU0067412154.USD","LU0314109678.HKD","LU0326950275.SGD","LU0880133367.SGD","KCAI","BK4588","IE00B031HY20.USD","LU1807302812.USD","LU1960683339.HKD","IE00B543WZ88.USD","VXUS","01093","IE0008368742.USD","IE00B5MMRT66.SGD","LU1328277881.USD","LU1226287875.USD","SG9999004220.SGD","LU1951186391.HKD","LU1152091168.USD","LU0315179316.USD","HK0000165453.HKD","LU1813983027.USD","IE0008369823.USD","IE00BZ08YT58.USD","LU1226288253.USD","LU0072913022.USD","LU1226287792.SGD","LU1226288170.HKD","BK1191","IE00BZ08YR35.GBP","LU0501845795.SGD","BK1515","LU1993786604.SGD","LU1226287529.USD","LU2039709279.SGD","KURE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660403439","title":"CSPC Pharmaceutical Hits 6-Month High on Profit, Dividend Surge","url":"https://stock-news.laohu8.com/highlight/detail?id=2660403439","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660403439?lang=en_us&edition=fundamental","pubTime":"2026-08-20 13:19","pubTimestamp":1787203167,"startTime":"0","endTime":"0","summary":"BUZZ-CSPC Pharmaceutical hits 6-month high on profit, dividend surge** Shares of CSPC Pharmaceutical Group1093.HKjump 17.1% to HK$10.17, their highest level since February 25** Stock on track for its biggest one-day pct gain since June 2012** Second-biggest percentage gainer on the benchmark Hang Seng Index.HSI, which gains 1.1%** Chinese pharmaceutical maker saidH1 profit attributablejumped 139% y/y with total revenue up 40% y/y driven by finished drugs growth** Co declares an interim dividend of HK$0.18 per share, up 28.6% from HK$0.14 each a year ago** YTD, stock up 16.9%, Hang Seng Biotech Index.HSBIOup 15.9%","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nL1N44H05B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0008369823.USD","LU1152091754.HKD","LU1226287875.USD","IE00B031HY20.USD","KURE","LU1008478684.HKD","LU1152091168.USD","IE00BZ08YS42.EUR","LU1951186391.HKD","SG9999004220.SGD","LU0072913022.USD","LU1960683339.HKD","LU0501845795.SGD","LU1813983027.USD","LU1993786604.SGD","LU0315179316.USD","HK0000165453.HKD","BK1191","LU0880133367.SGD","IE00BZ08YR35.GBP","LU1226287792.SGD","LU1807302812.USD","IE00BZ08YT58.USD","BK1515","LU1226288253.USD","LU0314109678.HKD","LU1226288170.HKD","LU2039709279.SGD","LU1226287529.USD","LU1328277881.USD","IE00B5MMRT66.SGD","01093","LU0067412154.USD","IE0008368742.USD","IE00B543WZ88.USD","BK1521","LU0140636845.USD","LU0326950275.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660403108","title":"Finland's Nanoform Q2 Ebitda Loss Narrows on Layoffs, Cost Cuts","url":"https://stock-news.laohu8.com/highlight/detail?id=2660403108","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660403108?lang=en_us&edition=fundamental","pubTime":"2026-08-20 13:18","pubTimestamp":1787203114,"startTime":"0","endTime":"0","summary":"Finland's Nanoform Q2 EBITDA loss narrows on layoffs, cost cutsOverviewFinland medicine performance-enhancer's Q2 revenue grew 16% yr/yr, adjusted EPS loss narrowedCompany's Q2 EBITDA loss narrowed as","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nL1N44H05H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BZ08YR35.GBP","01177","IE00BZ08YT58.USD","ONT.UK","BK1521","BK1589","HK0000165453.HKD","IE00BZ08YS42.EUR","BK1515","BK1191","BK5062"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660403998","title":"CSPC Pharmaceutical's Attributable Profit More Than Doubles in H1; Shares Jump 14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2660403998","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660403998?lang=en_us&edition=fundamental","pubTime":"2026-08-20 13:09","pubTimestamp":1787202587,"startTime":"0","endTime":"0","summary":"CSPC Pharmaceutical Group  reported an over 139% jump in attributable profit for the first half of 2026 to 6.09 billion yuan from 2.55 billion yuan a year earlier, according to a Thursday Hong Kong bourse filing.Earnings per share for the six months ended June 30 climbed to 0.5336 yuan from 0.2229 yuan in the prior-year period.Revenue of the pharma company jumped 40.1% year on year to 18.6 billion yuan from 13.3 billion yuan.The company declared an interim dividend of HK$0.18 per share, payable on Nov. 10 to shareholders of record on Oct. 26.Shares of the company jumped nearly 14% in recent trade.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0880133367.SGD","LU1951186391.HKD","IE00BZ08YS42.EUR","LU2039709279.SGD","IE00B543WZ88.USD","01093","LU0501845795.SGD","LU1226287792.SGD","SG9999004220.SGD","HK0000165453.HKD","FCA","IE00BZ08YR35.GBP","LU1993786604.SGD","LU1328277881.USD","IE0008368742.USD","BK1191","LU0315179316.USD","LU1226287529.USD","LU1152091168.USD","LU0326950275.SGD","LU0072913022.USD","LU1813983027.USD","LU1226288170.HKD","LU0140636845.USD","IE00B5MMRT66.SGD","KURE","LU0067412154.USD","LU0314109678.HKD","LU1152091754.HKD","LU1008478684.HKD","IE00BZ08YT58.USD","BK1515","IE00B031HY20.USD","IE0008369823.USD","LU1226288253.USD","LU1807302812.USD","LU1960683339.HKD","BK1521","LU1226287875.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660906408","title":"CSPC Pharma FY26 H1 Profit Attributable to Shareholders More than Doubled to RMB 6.09 Billion; Revenue Rises 40.1% to RMB 18.59 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2660906408","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660906408?lang=en_us&edition=fundamental","pubTime":"2026-08-20 12:19","pubTimestamp":1787199569,"startTime":"0","endTime":"0","summary":"CSPC Pharma FY26 H1 profit attributable to shareholders more than doubled to RMB 6.09 billion; revenue rises 40.1% to RMB 18.59 billionCSPC Pharmaceutical posted first-half revenue of RMB 18.59 billio","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nNDL6XHzX9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0880133367.SGD","IE00B5MMRT66.SGD","IE00B031HY20.USD","BK1515","IE00BZ08YT58.USD","LU1152091168.USD","LU1226287875.USD","LU1328277881.USD","KURE","LU0314109678.HKD","LU1226288253.USD","LU1807302812.USD","LU0315179316.USD","LU0326950275.SGD","LU0140636845.USD","LU1226287792.SGD","LU1951186391.HKD","IE00B543WZ88.USD","HK0000165453.HKD","LU1960683339.HKD","IE0008368742.USD","LU1226288170.HKD","01093","LU1993786604.SGD","BK1191","IE00BZ08YR35.GBP","LU1008478684.HKD","LU1152091754.HKD","LU0072913022.USD","LU0501845795.SGD","IE0008369823.USD","BK1521","LU0067412154.USD","LU1226287529.USD","IE00BZ08YS42.EUR","SG9999004220.SGD","LU1813983027.USD","LU2039709279.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660408970","title":"CSPC Pharmaceutical Group H1 Net Income Attributable RMB 6,094.2 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2660408970","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660408970?lang=en_us&edition=fundamental","pubTime":"2026-08-20 12:18","pubTimestamp":1787199533,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nPLXV00X44:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00BZ08YR35.GBP","LU1328277881.USD","LU1226287792.SGD","LU1813983027.USD","LU1152091754.HKD","IE00B543WZ88.USD","LU1993786604.SGD","BK1191","IE0008368742.USD","LU2039709279.SGD","IE00B5MMRT66.SGD","IE00BZ08YS42.EUR","KURE","LU0501845795.SGD","LU0072913022.USD","LU0067412154.USD","LU1951186391.HKD","LU0140636845.USD","LU0314109678.HKD","SG9999004220.SGD","LU1807302812.USD","LU1960683339.HKD","LU1226287529.USD","LU1226288170.HKD","BK1515","IE0008369823.USD","LU0326950275.SGD","IE00BZ08YT58.USD","BK1521","LU0315179316.USD","HK0000165453.HKD","LU1226287875.USD","01093","LU1226288253.USD","LU0880133367.SGD","IE00B031HY20.USD","LU1008478684.HKD","LU1152091168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660140897","title":"CSPC Pharmaceutical Group - Interim Dividend of HK18 Cents Per Share for 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2660140897","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660140897?lang=en_us&edition=fundamental","pubTime":"2026-08-20 12:18","pubTimestamp":1787199533,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nPLXV00X44:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1951186391.HKD","LU1226288170.HKD","LU0501845795.SGD","LU1807302812.USD","LU1226288253.USD","LU1960683339.HKD","LU0315179316.USD","LU1328277881.USD","KURE","IE00B031HY20.USD","LU1226287529.USD","IE00BZ08YT58.USD","LU0072913022.USD","IE00BZ08YS42.EUR","IE0008368742.USD","BK1515","IE0008369823.USD","LU0314109678.HKD","LU1008478684.HKD","LU1152091168.USD","IE00B543WZ88.USD","LU1993786604.SGD","IE00B5MMRT66.SGD","BK1191","LU2039709279.SGD","LU1152091754.HKD","LU0067412154.USD","IE00BZ08YR35.GBP","LU0880133367.SGD","LU1813983027.USD","LU0140636845.USD","01093","SG9999004220.SGD","LU1226287792.SGD","LU0326950275.SGD","HK0000165453.HKD","BK1521","LU1226287875.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178179537","title":"Market Opens Higher Across All Three Major Indices, Led by Precious Metals and Pharmaceuticals","url":"https://stock-news.laohu8.com/highlight/detail?id=1178179537","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1178179537?lang=en_us&edition=fundamental","pubTime":"2026-08-20 09:46","pubTimestamp":1787190382,"startTime":"0","endTime":"0","summary":"Trading data shows that on August 20, the Shanghai Composite Index opened up 0.33% at 3907.21 points, the Shenzhen Component Index opened up 1.03% at 14032.97 points, the ChiNext Index opened up...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["399300","159982","83130","09939","DBP","02827","BK1161","BK1515","03188","159938","83188","07233","BK1574","03130","82846","YSAG","02846","BK1147"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660147248","title":"Sinopharm to Sell 51% Stake in Guorui Pharmaceutical for 406 Million Yuan","url":"https://stock-news.laohu8.com/highlight/detail?id=2660147248","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660147248?lang=en_us&edition=fundamental","pubTime":"2026-08-20 09:46","pubTimestamp":1787190375,"startTime":"0","endTime":"0","summary":"Sinopharm  agreed to sell a combined 51% stake in China National Medicines Guorui Pharmaceutical for 406.4 million yuan, according to a Wednesday Hong Kong bourse filing.Sinopharm will sell a 30.13% direct stake for 240.1 million yuan, while its subsidiary Sinopharm  will dispose of a 12.06% stake for 96.1 million yuan.China National Pharmaceutical will sell the remaining 8.81% for 70.2 million yuan.Upon completion, Guorui Pharmaceutical will cease to be consolidated by Sinopharm, with Sinopharm  retaining a 49% stake and Shanghai Shyndec Pharmaceutical holding 51%.Sinopharm expects to record a preliminary gain of about 45 million yuan from the disposal, with proceeds to be used to replenish working capital.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1515","01099","BK1500","LU0640798160.USD","FCA","LU1115378108.SGD","BK1197"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158543575","title":"Hong Kong Stock Market Update: SBP GROUP Jumps Over 6% After Results, H1 Revenue Hits Record 19.44 Billion Yuan, Gaining Endorsements From Top Global Pharmaceutical Firms","url":"https://stock-news.laohu8.com/highlight/detail?id=1158543575","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158543575?lang=en_us&edition=fundamental","pubTime":"2026-08-20 09:34","pubTimestamp":1787189667,"startTime":"0","endTime":"0","summary":"SBP GROUP (01177) surged more than 6% at the market open following the release of its interim results, with shares climbing 6.05% to HK$5.08 at the time of writing, and transaction volume reaching...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1589","KCAI","BK1521","BK4588","BK1515","BK1191","01177","BK4585","IE00BZ08YR35.GBP","IE00BZ08YS42.EUR","HK0000165453.HKD","VXUS","IE00BZ08YT58.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1129240025","title":"Hong Kong Stock Alert: CansinoBio Jumps 15% as mRNA Cancer Vaccine Sector Gets Major Boost","url":"https://stock-news.laohu8.com/highlight/detail?id=1129240025","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1129240025?lang=en_us&edition=fundamental","pubTime":"2026-08-20 09:34","pubTimestamp":1787189660,"startTime":"0","endTime":"0","summary":"CansinoBio (06185) opened 15% higher in Hong Kong trading, with shares last up 15% at HK$26.84, recording a turnover of HK$3.88 million. The surge comes after Moderna and Merck announced on the...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VXUS","BK1161","BK1574","06185","BK4585","BK1515","159646","BK1191","BK4588","KCAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146381026","title":"US Treasury Steps In to Calm Markets, Ending Wall Street's Three-Day Slide, While Moderna's Cancer Vaccine Breakthrough Sends Shares Soaring 176%","url":"https://stock-news.laohu8.com/highlight/detail?id=1146381026","media":"Stock News","labels":["productRelease","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1146381026?lang=en_us&edition=fundamental","pubTime":"2026-08-20 09:10","pubTimestamp":1787188237,"startTime":"0","endTime":"0","summary":"Market Open Briefing1. US Treasury intervention steadies markets; Moderna surges 176%US stocks snapped a three-session losing streak after the Treasury Department moved to address bond market...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","BK4534","BK4551","02846","03188","159938","IDNA","WDNA","MRNX","BK4139","83188","03130","07233","09939","LGHT","BK4501","MRNA","02827","159982","BK1515","BK1147","GNOM","BK4585","BK4588","83130","BK1574","MRNY","399300","BK1161","BK4532","BK4548","82846","BK4533"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193023804","title":"GENFLEET-B Advances Two First-in-Class Pancreatic Cancer Combination Therapies into Phase II Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=1193023804","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1193023804?lang=en_us&edition=fundamental","pubTime":"2026-08-20 08:16","pubTimestamp":1787184978,"startTime":"0","endTime":"0","summary":"GENFLEET-B (02595) has announced the initiation of a three-arm, parallel-controlled Phase II clinical study evaluating GFH375, an oral KRAS G12D ON/OFF inhibitor. The trial will assess two novel...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","02595","BK1161","159938","BK1574","09939"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660479671","title":"China's Ascentage Pharma H1 Revenue Rises 29% on Lisaftoclax Ramp-up","url":"https://stock-news.laohu8.com/highlight/detail?id=2660479671","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660479671?lang=en_us&edition=fundamental","pubTime":"2026-08-20 07:17","pubTimestamp":1787181459,"startTime":"0","endTime":"0","summary":"China's Ascentage Pharma H1 revenue rises 29% on Lisaftoclax ramp-upOverviewChina oncology drug developer's H1 revenue rose 29% yr/yr on higher product salesNet loss widened as operating expenses and ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nL1N44G15G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1064130708.USD","LU0196878994.USD","BK1515","BK1574","LU1934453819.USD","BK1589","06855","IE00BZ08YT58.USD","002422","BK0060","LU1064131003.USD","LU2148510915.USD","IE00BZ08YS42.EUR","BK1521","BK0239","LU1979443071.USD","06990","HK0000165453.HKD","IE00BZ08YR35.GBP","01177","BK1191","BK1161"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":15,"pageCount":12,"totalSize":284,"code":"91000000","status":"200"}]}}